cell therapy company utilizing proprietary autologous tumor infiltrating lymphocytes (TILs) to attack solid tumors. Conducting pivotal stage trial in metastatic melanoma and cervical cancer, with BLA expected 2020, Additional company-sponsored trials: head & neck cancer, non-small cell lung cancer, and earlier lines in melanoma. IST collaborations in ovarian cancer, bladder cancer, sarcomas, adenocarcinoma, and pancreatic cancer.
999 Skyway Road
San Carlos, CA 94070
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Solebury Trout Management Access: SF 2020
San Francisco, CA, United States,
January 13 –
January 16, 2020
Stock Market Data
Market Data copyright © 2019 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by